Medical Condition

autism

Total Trials

12

Recruiting Now

12

Trial Phases

Various

Autism spectrum disorder (ASD) trials target core symptoms (social communication, restricted/repetitive behaviors) as well as co-occurring conditions including anxiety, sleep disturbance, and gastrointestinal problems. The heterogeneity of ASD — driven by hundreds of genetic variants — has driven interest in genotype-stratified trials that enroll specific genetic subtypes (SHANK3, CHD8, FMR1).

Trials evaluate oxytocin nasal spray, vasopressin receptor modulators, mGluR5 antagonists in fragile X, bumetanide (GABA modulator), transcranial magnetic stimulation, and early intensive behavioral interventions. Biomarkers including EEG connectivity measures and eye-tracking are being validated as objective outcome measures.

Frequently Asked Questions — autism Clinical Trials

How many clinical trials are currently recruiting for autism?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for autism, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for autism?

autism research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a autism clinical trial?

Eligibility criteria for autism trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology

autism

Frequently Asked Questions — autism Clinical Trials

Recruiting Clinical Trials

Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth

Music Therapy for Speech and Prosody in Autistic Children (MTSPAC)

COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD

Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Sensory Phenotypes of Autism Spectrum Disorder

Piloting the Competence in Romance and Understanding Sexual Health Curriculum

Neuroimaging Predictors of Improvement to Pivotal Response Treatment (PRT) in Young Children With Autism

Word Learning From Parentese in Autistic Children

Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety

Where Wild Things Grow: Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth

Safety and Efficacy of Fecal Microbiota Transplantation

Parent-Mediated Intervention Targeting Insistence on Sameness for Autistic Children